424 related articles for article (PubMed ID: 19689543)
1. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
Craiglow B; Hinds G; Antaya R; Girardi M
Pediatr Dermatol; 2009; 26(4):493-5. PubMed ID: 19689543
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous infection by Fusarium: successful treatment with oral voriconazole.
Guimerá-Martín-Neda F; García-Bustínduy M; Noda-Cabrera A; Sánchez-González R; Montelongo RG
Br J Dermatol; 2004 Apr; 150(4):777-8. PubMed ID: 15099384
[No Abstract] [Full Text] [Related]
3. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
4. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
5. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Chow E; Moore T; Nielsen K
Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
[TBL] [Abstract][Full Text] [Related]
6. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
7. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
Tunçcan ÖG; Aki ŞZ; Akyürek N; Sucak G; Şenol E
J Infect Dev Ctries; 2011 May; 5(5):406-9. PubMed ID: 21628821
[TBL] [Abstract][Full Text] [Related]
8. Disseminated cutaneous histoplasmosis in an immunocompetent child, relapsed with itraconazole, successfully treated with voriconazole.
Dhawan J; Verma P; Sharma A; Ramam M; Kabra SK; Gupta S
Pediatr Dermatol; 2010; 27(5):549-51. PubMed ID: 20796238
[TBL] [Abstract][Full Text] [Related]
9. [Primary cutaneous aspergillosis in an immunocompetent farmworker].
Camus M; Anyfantakis V; Dammak A; Riche A; Delouane H; Roblot F; Guillet G
Ann Dermatol Venereol; 2010 May; 137(5):373-6. PubMed ID: 20470919
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous aspergillosis in renal transplant recipient.
Gupta A; Khaira A; Lata S; Sharma A; Tiwari SC
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):848-9. PubMed ID: 19736488
[No Abstract] [Full Text] [Related]
11. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
12. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Panicker J; Walsh T; Kamani N
Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998
[TBL] [Abstract][Full Text] [Related]
13. Sporotrichoid aspergillosis in an immunocompromised child: a case report and review of the literature.
Palmero ML; Pope E; Brophy J
Pediatr Dermatol; 2009; 26(5):592-6. PubMed ID: 19840318
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous infection with Scedosporium apiospermum successfully treated with voriconazole.
Stur-Hofmann K; Stos S; Saxa-Enenkel M; Rappersberger K
Mycoses; 2011 Jul; 54(4):e201-4. PubMed ID: 19925568
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
Howard A; Hoffman J; Sheth A
Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
La Nasa G; Littera R; Maccioni A; Ledda A; Vacca A; Contu L
Hematol J; 2004; 5(2):178-80. PubMed ID: 15048069
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient.
Laza-Stanca V; Reid L; Watson JD; Williamson EC
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1259-61. PubMed ID: 22391464
[TBL] [Abstract][Full Text] [Related]
18. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
19. Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.
Azofra MM; Somovilla JL; Porras MC; Carrillo LH; Pérez RD
Clin Infect Dis; 2010 Jul; 51(2):255-7. PubMed ID: 20560740
[No Abstract] [Full Text] [Related]
20. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
